Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

European generics firms, squeezed between innovators and payers, seek diversity

This article was originally published in SRA

Executive Summary

Mixed sentiments about the future of the European generic medicines sector were in evidence at the annual meeting of the European Generic medicines Association in Lisbon on 16-17 June1. Upbeat forecasts from industry figures contrasted with a more downbeat assessment from some consultancy firms in the face of the innovation slowdown, competition from R&D firms and the challenges posed by the biosimilars market.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS116289

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel